Compounded Tirzepatide (GLP-2) 10mg

$125.00
Limit 4 per order

What is Tirzepatide?

Tirzepatide is a once-weekly injectable medication that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These naturally occurring hormone pathways help regulate appetite, blood sugar, and food intake.

Potential Benefits

  • Significant Weight Loss: Clinical studies have demonstrated substantial weight reduction when tirzepatide is combined with healthy nutrition and physical activity.

  • Appetite Control: Helps reduce hunger, cravings, and overall food intake.

  • Improved Blood Sugar Regulation: Supports glucose control and insulin response, particularly in patients with type 2 diabetes.

  • Increased Satiety: Slows gastric emptying, helping patients feel fuller for longer periods.

  • Improved Metabolic Health: Weight reduction may improve certain cardiometabolic risk factors, including blood pressure and cholesterol levels.

Common Side Effects

The most frequently reported side effects are gastrointestinal and may be more noticeable when beginning treatment or increasing the dosage.

  • Nausea or vomiting

  • Diarrhea or constipation

  • Abdominal discomfort, bloating, or indigestion

  • Decreased appetite

  • Acid reflux or burping

  • Injection-site reactions

  • Fatigue

Many gastrointestinal side effects improve as the body adjusts to treatment.

Important Safety Information

Tirzepatide may cause serious adverse effects, including pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions, and allergic reactions. Low blood sugar may occur, particularly when combined with insulin or certain diabetes medications.

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Tirzepatide is not recommended for patients with severe gastroparesis. Patients should inform their provider if they are pregnant, planning pregnancy, breastfeeding, or using oral hormonal contraceptives, as additional precautions may be necessary.

Our Approach at Scottsboro Weight Loss

At Scottsboro Weight Loss, we believe successful weight management requires more than medication alone. Our providers develop individualized treatment plans incorporating nutritional guidance, body composition monitoring, lifestyle modifications, and ongoing medical supervision.

Our goal is to help patients achieve sustainable weight management while prioritizing safety, overall health, and long-term success.

Compounded Tirzepatide is not FDA-approved and has not undergone FDA review for safety, effectiveness, or quality. Compounded medications may be prescribed only when legally permitted and clinically appropriate for an individual patient's medical needs. Results vary, and treatment requires evaluation by a licensed healthcare provider.

What is Tirzepatide?

Tirzepatide is a once-weekly injectable medication that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These naturally occurring hormone pathways help regulate appetite, blood sugar, and food intake.

Potential Benefits

  • Significant Weight Loss: Clinical studies have demonstrated substantial weight reduction when tirzepatide is combined with healthy nutrition and physical activity.

  • Appetite Control: Helps reduce hunger, cravings, and overall food intake.

  • Improved Blood Sugar Regulation: Supports glucose control and insulin response, particularly in patients with type 2 diabetes.

  • Increased Satiety: Slows gastric emptying, helping patients feel fuller for longer periods.

  • Improved Metabolic Health: Weight reduction may improve certain cardiometabolic risk factors, including blood pressure and cholesterol levels.

Common Side Effects

The most frequently reported side effects are gastrointestinal and may be more noticeable when beginning treatment or increasing the dosage.

  • Nausea or vomiting

  • Diarrhea or constipation

  • Abdominal discomfort, bloating, or indigestion

  • Decreased appetite

  • Acid reflux or burping

  • Injection-site reactions

  • Fatigue

Many gastrointestinal side effects improve as the body adjusts to treatment.

Important Safety Information

Tirzepatide may cause serious adverse effects, including pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions, and allergic reactions. Low blood sugar may occur, particularly when combined with insulin or certain diabetes medications.

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Tirzepatide is not recommended for patients with severe gastroparesis. Patients should inform their provider if they are pregnant, planning pregnancy, breastfeeding, or using oral hormonal contraceptives, as additional precautions may be necessary.

Our Approach at Scottsboro Weight Loss

At Scottsboro Weight Loss, we believe successful weight management requires more than medication alone. Our providers develop individualized treatment plans incorporating nutritional guidance, body composition monitoring, lifestyle modifications, and ongoing medical supervision.

Our goal is to help patients achieve sustainable weight management while prioritizing safety, overall health, and long-term success.

Compounded Tirzepatide is not FDA-approved and has not undergone FDA review for safety, effectiveness, or quality. Compounded medications may be prescribed only when legally permitted and clinically appropriate for an individual patient's medical needs. Results vary, and treatment requires evaluation by a licensed healthcare provider.